Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00500929Phase 2Completed
Phase 2, randomised, double-blind trial of dichloroacetate (2 arms), sponsored by CardioMetabolics. Primary endpoint: Intensive Care Unit Time. Started Jul 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00500929.